UCB (Jefferies) | Vlaamse Federatie van Beleggers
6
0
0
Hele tekst
(2) .
(3) . .
(4)
(5) ! "##$% &
(6) ! '(
(7) . & '(( (()(. !. " !#$ %! &
(8) '(' )*+
(9) ',- - ! - ..)!-
(10) /-+0,- !
(11) * % $ ! )
(12)
(13) / %
(14)
(15) )
(16) -123%
(17). -+453,%
(18) %- /
(19) ! 67 - -
(20)
(21)
(22) - ! 849
(23) ' 4 !
(24) * ) 0 &')!
(25) )
(26) / - * )* *- - % -.
(27) -
(28)
(29)
(30) -$* /- .
(31) - &'-:1; -
(32) < =
(33)
(34) -- - ... )( - .. > :( ; (( (88 ( <(.=>/( ?
(35) ( 3 0@$+? (( 3 3 < ( (( (< ( ((3 (!A(); !@ ?)- B'(3 ( 888=> < ( C!D?33 33; ( ( ( (!:(( (( ( < ( ?) 3) ( ( (. 3 ( 3 (3 ( / E=> ; 1!@F<(!00! F G3 #1F<(!0 F ■ ■. =>-H9 ; % !2F<(!@ !2F G3 #F<(!. F . - .. )--
(36) )
(37) ! > A ( 88 < ; <(! . % => ( (( ) ( (! 8 ? ( < )I .E:/ 3( ( 3 ; JI < 3 )I ! - 3 ( ? ) ; ( 3 "! ( E <=>.E=>/(.K"!00@/?3(( ! C ( ) B ? ) ( 3 @!1 < . =>(.=>/(.K"!"1$/ ( 3 @!%< =>-<( 3 H 9< .=>-H9/ ( .K"!" 2/! + ? ( (( (( ( ( ( 3 ( 3 ( =>-H9(30!".K"!""1/? )( ( ( ( !8 0? () ( < 3 (( 3 ; JI %JI E:? )
(38) 3 ( (( ((! D) ) )I( 3 ; ?(8> ( #2F?)( ()< ; JI ( ( 21F 3 ( 8>. . -/ ( ( ( )! - %
(39) !>
(40) ( ; ) (( 3 ) ? ) ( 8 8A ( ! )<? )( ( . 3, ) ; .# !@F/ .@ !2F/ () (B ?). # F3, ( %"F (88 8A ?. F 3 3 ( => ! D? .@%F/ ; ()) ) 3( ??)) (( ((< ? ) <( ) ( ( .C/ ; ! ? (< I )8L;
(41) (C3 ! - () ( (< )( !: ) 33 ( 3 3 (!.
(42)
(43) * +, - ( %%."/0" "0$1221)3 4533(!.
(44)
(45) * +, - (. %%."/0" "0$12 # 4533(!. !
(46) * +, - (. 6%%."/0" "0$1# " 4533(!. *733(8 9. ?. * -
(47)
(48) ' . >
(49) ( ( 3 ( 3 .8H /?) (88( (B ( @E@$+!: ( ; '( 8H => 8A ((M@!# I( ( "F ?)M #" 8H ! - B . (( 3 (88 8H @@$+!. Please see analyst certifications, important disclosure information, and information regarding the status of non-US analysts on pages 2 to 6 of this report.. )*+,$-./. .
(50)
(51) !"" #!$%&.
(52) UCB BB Company Update 18 October 2018. )! -
(53) 67
(54) ( ( ( ) ,( (3 0""% C) ; 0""2!A. 3(( ) (3NC ?( ( ( (!
(55) '(I(( O I 0""1)
(56) C B !A '(I ( L .( /?; . (? '( ( ( ( (/? N. I ( '( ( (/!. )!= ;&-$67 P A ( ( N L (3 ( < ! (I( .@/ ( J ( J (((3 (G.0/ ; 3( (G. / ( I( +< ?I; . ; B; !. !-
(57) > 8? :3 ?D-?3 3<)(B(( (( 3 ( <)( (5( .(/. (5 .(/!8 (3 3 ( ) (?(?)? ? (3 ( <)(B(( (( ! 8? > ? + !H!? 3 3 <)( B(( ( ( 3 ( <)( (5 ( .(/ (5 .(/!8 (3 3 ( ) (?(?)? ? (3 (<)(B(( (( ! 8?9 ?3 3<)(B(( (( 3 ( <)( (5( .(/. (5 .(/!8 (3 3 ( ) (?(?)? ? (3 ( <)(B(( (( ! & -
(58) 6?!- -> :3 ?D-( 733(8 9 ?
(59) C 33 3733(99 ( ( J, 3 ( ( ()D8N-!A( (.(/ (( ( 3733(99? D8N-3?. 3 (5D8N-00%@ ( ( () (5 ? ( (( ( (! & -
(60) 6?!- -> > ?+ !H!( 733(8 9 ?
(61) C 33 3733(99 (. ( J, 3 ( ( ()D8N-!A( (.(/ (( ( 3733(99? D8N-3?. 3 (5D8N-00%@ ( ( () (5 ? ( (( ( (! & -
(62) 6? !- -> 9 ( 733( 8 9 ?
(63) C 33 3 733( 99 ( ( J, 3 ( ( ()D8N-!A( (.(/ (( ( 3733(99? D8N-3?. 3 (5D8N-00%@ ( ( () (5 ? ( (( ( (! -( ( ( ) 733( (? (.(/ ( ( 3 < 3 3. ( ( ((( ( <( ( ( < 3 3 3? <( I ! : (I ( ( ?< ( ( < (3 (!-( 3 ( (( ((? 5 3( ( < ( ( ('(5 !. ./ - ) & )) &
(64) +
(65) @+4,
(66) 20&, ( H(. P@1?0"@1?"0 #2+A! P@1?0"@1?"0 #2+A!. ( A
(67) -& H(((( )B< . ( /3@#F) @0 ! H(((( )B< . ( /3(@#F (@"F) @0 !
(68) 3H(((( )B< . ( /3 (@"F(() @0 ! AB . ( /3 (() < ( (( )M@"(0"F ) @0 ( ( ( < < (I I! D (( ) < ( (( )M@"?B . ( /(( (0"F) @0 !D
(69) 3 (() < ( (( )M@"?B . ( /( ( 0"F(() @0 ! NA <( < (( !C(( ( ( ) ( J 733((! C< C( !733( ((( < 3( ! NN< !733( ( <( ! ( H((((()? 5 )733( ( (? (( ( (3 (? <( (! = H(((()( 3 ( 3. ( ? 3) 3. 5 ( ( <( (3 < ! page 2 of 6. Please see important disclosure information on pages 2 - 6 of this report.. Peter Welford, CFA, Equity Analyst, 44 (0) 20 7029 8668, pwelford@jefferies.com.
(70) UCB BB Company Update 18 October 2018. = 0 ! 733(' 3 (( ( 3) I ; ? ? )J< ? < B < B@0 (!A ( ( (< (?) ? ( ? ((3 I (I?) ?< ( ? ( (3).HD/?+8AH-?+ C? (3).D/?3 (3).DD/?+LJ+8AH-? J+? +J)? JD? J DD?. ( /J < +LJ+8AH-?. ( /J < J+?(3 (? ((< ? < (?. , .P+/< B@0 (! A
(71) -
(72) - $733(D ( I( (I( (3 ((I (3, ((< @0 !CI(. ( ( 3 (( I 3 (( ( ( < ? 33 ((? 3 < (IJ) <( ( 733( (( !733(D ( I() (I( < ( (3 ( !CI() ( ) ( ( < ) ( 3 ( (?(I (( ( ?3( J3( (((!CI( < @0" < . , 3CQ (I() < @#F(((? ) < 0"F(!D ( I( ( 33(I( ( ( ( ?) ))< I3 () <( ( ( ()< !. &-$-% )!) / )
(73)
(74) #
(75) . A() ( 3 ( < <( ((3 < <((!-((?3. ( ( ((( ( ( 3 <(( <((( I) <( ( ( ( (3 <( 5<( 3. ( ; ) 3. <(( ( (( ! (3 33. ( ( (( I ( 33((!A?< 3? 3?. 33. ( ( ( ( () (3 33 ( ?3. 3 (!83 3. ( ( <('( ? B ( <( 33 3?< 3? < 33. ( ( (!8 ? <(( ((( (-H(?)( < ( 33 3 ( ?33< (( (I!. < ->+ B A ( <( ( (< ( ( ) ( ? 3 ( < 3 ! 9 8 8 < H H <
(76)
(77) 3 D8 H(( 3 ( (? (<()( ( JJ5 < ! B!J(( J H(((! 0@0!01%!0 ""!. page 3 of 6. Please see important disclosure information on pages 2 - 6 of this report.. Peter Welford, CFA, Equity Analyst, 44 (0) 20 7029 8668, pwelford@jefferies.com.
(78) UCB BB Company Update 18 October 2018. -
(79) * & IB Serv./Past 12 Mos.. JIL Mkt Serv./Past 12 Mos.. Rating. Count. Percent. Count. Percent. Count. Percent. BUY HOLD UNDERPERFORM. 1168 829 117. 55.25% 39.21% 5.53%. 95 15 0. 8.13% 1.81% 0.00%. 15 0 0. 1.28% 0.00% 0.00%. page 4 of 6. Please see important disclosure information on pages 2 - 6 of this report.. Peter Welford, CFA, Equity Analyst, 44 (0) 20 7029 8668, pwelford@jefferies.com.
(80) UCB BB Company Update 18 October 2018
(81) .)
(82) - -
(83) 733( ( (I( ( (() (< (( (!-( (? <((( ) 733( < 33 ( 335< 3(!8 <((( ( ( ( ( 3 I <( ( ! 733( +, ( 3( ( ( (( 3 3) 733( > 99 .R733(S/ ( 6 ? ->733(99)( C+( I 3D8N-. ( 733(( C<(?99?. C+( 8 <( - <(? ( ( 3(( /! 6 " )>733(8 9 ?)( ; D. - G( + . : (N!@$ 120@G( 33 L ( ?21
(84) A (C?9 +%L 7G 6%%."/0" "0$1"""G3 (6%% ."/0" "0$1"@"! " >733( O 9 ?)( ( C( D((( 3 O )+ -AC#%2G C00"@?00 D? O ?0E T( ? O ! ?
(85) >733(C 9 ?)( ( = - 3C G 1" 33( U@#0"?
(86) P ; 0? C "%120%? 62#2##@ $#"! A>733(.7 /9 ?AI ?)( (( ( D. C<(- 37 ( 37 C(H (-(( G = ? D?@#@V I? I?AI @"""""2G 61@ #0#@ 2@""G3 (61@ #0#@2@"@! .>733(8 < 9 .8N
(87) %@%"=0"" A0""#"$/?)( ( C( +B 38 ( = I.8N=""""@@%% /?( - (.8N"""""" "@/ CII) CI+B 9 .8N"@@%$@" / N CI+B 38 9 .8N0 @%$@" / = IC G %0J% ?0N-< ?= I= B ? O B? .+ (/= %"""#@?8 GA6$@00% #22"""! A() ( (. ) (( )733(.733(8 9 ?733( O 9 ?733(C 9 ?733(.7 /9 ?733(8 < 9 /G (. ) (( )733(99 733(( C<(99.R7CS/!733(99(
(88) C( I ( 33 )7C?)(
(89) C( <( <(!7C ( ( ; ( ( < 7C(( !83 ( 3(( ?( < 7C!P)(?( < 733(99!733(99?7C? 33 ( < 3 ) (R733(S! 733( (I ( (() (< (( !-( (? <((( ) 733( < 3 3 ( 335< 3(!8 <((( ( ( ( 3 3 ( I <( ( (!C3 33 ( ((( , D8N- ( (3 ( ((( ! *** 83 < (3
(90) C733( ? ( 3)
(91) (( <( (3 C3
(92) !C! C(-3@$ ? ( ?( ( (
(93) C ( 733(99?) (( ( 3( (. )<( (3@# 2
(94) CC(+B -3@$ %? ( !A ( ( 33
(95) C(. 33 733(99!8
(96) O + + - (((( J < 3 (. 733( 8 9 .R789S/ ( 3 ( ( ( ) <? < (((( ( < ? ( 3(( B B(? ( () )( )3 ( ! 789 )(( (( I< ( )I!789T( 3( (( (789 ( . 3(3 ( ( ( (3( ( )I!733(99?789 33 (? I I< , 3. ( (3 (G ) I I?( < ( (( (3 ( R (3 (((S! D <((?( ( 3( 3(( ( <((!N 3 <( ( <( (<( ( ( < ( ( )( H( 8 ( ( 3 C( -.P /!8 C ?733(C 9 .R7C9S/( = - 3C !D <(( 3 C ?( (< 7C9( 03D. - <(( (!A ( ( ( 3 ?B ( <((? ( 3 C( D(-. !01$3C /!83 . ( ( 3? . )( ? ( 7C9? 1" 33( U@#0"?
(97) P ; 0?C "%120%? 62#2##@ $#"!8 7 ?( ((( ( 733(.7 /9 ( <(( !8 O ? (((( < 733( O 9 ( 3( 3(( <(( ( 3 O C( D(P . ((( ( !8 3 .A ) /?(( ( !A( (( ( T(3 .R S/!A( ( ( 33(( . 3 33 (( ! <((( << , 3 ( <( ((( ( ( (3 < < (? ((?<3 ( J( (3< < ((<(!8 8 ?( ( < 733(8 < 9 !8 -( ?( 3 ((( ( 789 ( ( )( (). 3 (-0""@3-( .-/? . ) ( 3 <( <( (< ((53( !- 33(( ((53( ( ,? ( ( ? (( ((( ) 3-!789( ( D. - )(3
(98) O ?) 333-( )(!789 ( 3 -( C( 8 <( (((. ((P " J@"$$?) B(3 -( 3. (<( ( - (3<( 3 3. (<()( (! (3( 5( (( 3(<( (<. , ( 3( ! A(( 33( 3 33 ( ( < < ( ? I <( !- ( (( '((5 (3 3 ? ((5 ) !733( ((( . ( ( ((, 3 < (!733(? (<33(? (? (? < (( ( ? ( 3((? < < ( ( <( ( ( ? ( ( 3) !A( (< ( 3 3 (( ( ?. ( ( ? ( I ? <( 5<(?3 (?( ?3. ( ? ( 3 !-((? < ( ( 3 !733( ((( (3 ( 3< 3 3B( 5 !- 3(( I <( ( )3( ( ) < ((( 3 ( . T( ( ( ?3 )( ?(I 3(( <? B <!733( ( page 5 of 6. Please see important disclosure information on pages 2 - 6 of this report.. Peter Welford, CFA, Equity Analyst, 44 (0) 20 7029 8668, pwelford@jefferies.com.
(99) UCB BB Company Update 18 October 2018 3 ( ((I) <( ( ( (( (( ) T( <( 5<(?3 (?( ?3. ( ? ( < (? 7C 733( ( ? ( ? < 3 T( (((!- I 3(? ( 3 ?( T((5 (I!A (3() <)3 (< <( !83 (((<(3733(99. 33 I (/? . ) (( 3 ( ( (53( (?(I ( 3( ) ( ( 3 ( !P 7C(( )C+ ( <( <(G 3 733(99 . 733( 33 ( 3 . ) ( 3((! A < 3 <( ( 3 3 3 ! ( 3 ( 3 3 ?3 ( ? ((3 !D ( B ( < <(33(. < 3? < 3? <( (! A( ( 3 ((3(( ( 3 ((3((!N+, ( (. < ) (< I ( () 33((.(/!- (( ( . (3733( ( 333<)(3733( (! A( 3 3 (? (3 ( (( (C Q T(! . ( 3 3( B)) (( 3 !733( ( ? ((? (( < 3 3 ? (? ( ( (3 ((( ( . )(/? ((3 (?3(( 3(3( !A < (< B(( ) (? ? ? ) (3 3 ((3 ((!N733( . < ( 3 ? ? ?B ? ( ? <?( (, (? ((?B ((? 3(?(((. ( 3( ((/ . ) (3 ? (! ( ( (3 ( ( (33 ( (? (((!A ((( 3((( 3((3 <( ((? ( ( <( <! 733(( ( (( < ? ? ( ((? ( 3!+ ( (( ( < (!A( 3 ?( ( )) ( 3733(! N733( 3((< (?33( (?(( (3 3. (((3 <( ? ( ) (<3 ? (, (((( ( 3 (3(( (!N ( ( ) < 733( (
(100) !C!3 ( (( )(! D 8 H(( 3 7C? ( ( ( JJ <( 3!(!<J8- HJ J J W W! (BX WLCNW8HK%1 1 1 ( JJ <( 3!(!<JDJ0$0@%0 <( )( ( JJ5 < ! B!J(( J H(((! ?)))!533(!? @!111!7+DD+8+C! Y0"@1733(>99. page 6 of 6. Please see important disclosure information on pages 2 - 6 of this report.. Peter Welford, CFA, Equity Analyst, 44 (0) 20 7029 8668, pwelford@jefferies.com.
(101)
GERELATEERDE DOCUMENTEN
Registration of non-US analysts: Peter Welford, CFA is employed by Jefferies International Limited, a non-US affiliate of Jefferies LLC and is not registered/qualified as a
This analyst(s) may not be an associated person of Jefferies LLC, a FINRA member firm, and therefore may not be subject to the FINRA Rule 2241 and restrictions on communications with
Jefferies International Limited has implemented policies to (i) address conflicts of interest related to the preparation, content and distribution of research reports,
This analyst(s) may not be an associated person of Jefferies LLC, a FINRA member firm, and therefore may not be subject to the FINRA Rule 2241 and restrictions on communications with
Jefferies International Limited has implemented policies to (i) address conflicts of interest related to the preparation, content and distribution of research reports,
On the other hand, OBEL is facing a material headwind in the form of high-margin MVNO revenue loss in 2018e/19e, the rapidly growing cable revenue is coming with significant
In April 2016, Ablynx reported positive top-line results of the Phase I/IIa study of ALX-0171 in 53 infants aged 1-24 months hospitalised with RSV infection.. After an initial
Group review: Sound results driven by lower opex, as expected revenues are seasonally under pressure and confirming Q2 trends on NIM.. Provisions were slightly
